These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31091275)

  • 1. Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study.
    Najjingo I; Muttamba W; Kirenga BJ; Nalunjogi J; Bakesiima R; Olweny F; Lusiba P; Katamba A; Joloba M; Ssengooba W
    PLoS One; 2019; 14(5):e0216901. PubMed ID: 31091275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
    Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
    BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
    Muttamba W; Ssengooba W; Sekibira R; Kirenga B; Katamba A; Joloba M
    PLoS One; 2018; 13(3):e0194741. PubMed ID: 29566056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Xpert MTB/RIF with measures to assess Mycobacterium tuberculosis bacillary burden in high HIV burden areas of Southern Africa.
    Beynon F; Theron G; Respeito D; Mambuque E; Saavedra B; Bulo H; Sanz S; Dheda K; Garcia-Basteiro AL
    Sci Rep; 2018 Mar; 8(1):5201. PubMed ID: 29581435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Sinshaw W; Kebede A; Bitew A; Tesfaye E; Tadesse M; Mehamed Z; Yenew B; Amare M; Dagne B; Diriba G; Alemu A; Getahun M; Fikadu D; Desta K; Tola HH
    BMC Infect Dis; 2019 Jul; 19(1):641. PubMed ID: 31324227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xpert MTB/RIF Ultra CT value provides a rapid measure of sputum bacillary burden and predicts smear status in patients with pulmonary tuberculosis.
    Martin-Higuera MC; Rivas G; Rolo M; Muñoz-Gallego I; Lopez-Roa P
    Sci Rep; 2023 Jan; 13(1):1591. PubMed ID: 36709214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppression.
    Hanrahan CF; Theron G; Bassett J; Dheda K; Scott L; Stevens W; Sanne I; Van Rie A
    Am J Respir Crit Care Med; 2014 Jun; 189(11):1426-34. PubMed ID: 24786895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic.
    O'Grady J; Bates M; Chilukutu L; Mzyece J; Cheelo B; Chilufya M; Mukonda L; Mumba M; Tembo J; Chomba M; Kapata N; Maeurer M; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Clin Infect Dis; 2012 Nov; 55(9):1171-8. PubMed ID: 22806590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda.
    Ngabonziza JC; Ssengooba W; Mutua F; Torrea G; Dushime A; Gasana M; Andre E; Uwamungu S; Nyaruhirira AU; Mwaengo D; Muvunyi CM
    BMC Infect Dis; 2016 Nov; 16(1):660. PubMed ID: 27825314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    Rice JP; Seifert M; Moser KS; Rodwell TC
    PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
    Khalil KF; Butt T
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda.
    Ssengooba W; Nakiyingi L; Armstrong DT; Cobelens FG; Alland D; Manabe YC; Dorman SE; Ellner JJ; Joloba ML
    PLoS One; 2014; 9(9):e107595. PubMed ID: 25222866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Loopamp™MTBC detection kit for diagnosis of pulmonary tuberculosis at a peripheral laboratory in a high burden setting.
    Nguyen VAT; Nguyen HV; Dinh TV; Du HH; Do CN; Marks GB; Nguyen NV
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):190-195. PubMed ID: 29246776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
    Calligaro GL; Theron G; Khalfey H; Peter J; Meldau R; Matinyenya B; Davids M; Smith L; Pooran A; Lesosky M; Esmail A; Miller MG; Piercy J; Michell L; Dawson R; Raine RI; Joubert I; Dheda K
    Lancet Respir Med; 2015 Aug; 3(8):621-30. PubMed ID: 26208996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
    van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
    PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings.
    Tadesse M; Abebe G; Abdissa K; Aragaw D; Abdella K; Bekele A; Bezabih M; Apers L; de Jong BC; Rigouts L
    PLoS One; 2015; 10(9):e0137471. PubMed ID: 26366871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.